thiophenes has been researched along with eprosartan mesylate dihydrate in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Duddu, SP; Grant, DJ; Sheng, J; Venkatesh, GM | 1 |
| Berezov, VP; Boĭko, AN; Gusev, EI; Martynov, MIu; Maskarov, AN; Petukhov, EB | 1 |
| Claassen, JA; Heerschap, A; Kiliaan, AJ; Roelofs, M; van der Lugt, R; Wiesmann, M | 1 |
| Ahad, A; Ahmad, A; Al-Jenoobi, FI; Al-Mohizea, AM; Raish, M | 1 |
| Bagul, M; Edwankar, D; Pokharkar, V; Shekhawat, P | 1 |
5 other study(ies) available for thiophenes and eprosartan mesylate dihydrate
| Article | Year |
|---|---|
Dehydration behavior of eprosartan mesylate dihydrate.
Topics: Acrylates; Algorithms; Antihypertensive Agents; Calorimetry, Differential Scanning; Crystallization; Desiccation; Drug Stability; Hydrogen Bonding; Imidazoles; Kinetics; Models, Molecular; Particle Size; Tablets; Temperature; Thermogravimetry; Thiophenes; X-Ray Diffraction | 1999 |
[Eprosartan mesylate in controlling of blood pressure in patients with ischemic stroke].
Topics: Aged; Antihypertensive Agents; Brain; Brain Ischemia; Cerebrovascular Circulation; Female; Humans; Hypertension; Imidazoles; Male; Middle Aged; Thiophenes | 2002 |
Angiotensin II, hypertension and angiotensin II receptor antagonism: Roles in the behavioural and brain pathology of a mouse model of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Behavior, Animal; Blood Pressure; Brain; Cerebrovascular Circulation; Disease Models, Animal; Hypertension; Imidazoles; Maze Learning; Mice, Transgenic; Spatial Learning; Thiophenes | 2017 |
Eprosartan mesylate loaded bilosomes as potential nano-carriers against diabetic nephropathy in streptozotocin-induced diabetic rats.
Topics: Administration, Oral; Angiotensin II Type 1 Receptor Blockers; Animals; Bile Acids and Salts; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Drug Carriers; Drug Delivery Systems; Drug Liberation; Imidazoles; Liposomes; Male; Nanostructures; Particle Size; Rats; Thiophenes | 2018 |
Enhanced dissolution/caco-2 permeability, pharmacokinetic and pharmacodynamic performance of re-dispersible eprosartan mesylate nanopowder.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Blood Pressure; Caco-2 Cells; Drug Carriers; Drug Compounding; Humans; Imidazoles; Male; Nanoparticles; Permeability; Powders; Rats, Wistar; Solubility; Thiophenes | 2019 |